Overview
Jahan Aghalar is an Oncologist in Bayside, New York. Dr. Aghalar is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, and Muscle Invasive Bladder Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4564 Francis Lewis Blvd, Suite 202, Bayside, NY 11361
5 Cuba Hill Rd, Greenlawn, NY 11740
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Memorial Solid Tumor Group
Darren Feldman is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy.
Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Orchiectomy, and Nephrectomy.
Memorial Solid Tumor Group
Samuel Funt is an Oncologist in New York, New York. Dr. Funt is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Urothelial Cancer, Testicular Cancer, Teratoma of the Mediastinum, Bladder Cancer, and Orchiectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Clear Cell SarcomaDr. Aghalar isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Aghalar isDistinguished. Learn about Familial Prostate Cancer.
- Laryngeal CancerDr. Aghalar isDistinguished. Learn about Laryngeal Cancer.
- Muscle Invasive Bladder CancerDr. Aghalar isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Aghalar isDistinguished. Learn about Prostate Cancer.
- Urothelial CancerDr. Aghalar isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Aghalar isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Aghalar isAdvanced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Aghalar isAdvanced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Aghalar isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Endometrial CancerDr. Aghalar isAdvanced. Learn about Endometrial Cancer.
- Familial Pancreatic CancerDr. Aghalar isAdvanced. Learn about Familial Pancreatic Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Aghalar isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adrenal CancerDr. Aghalar isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Aghalar isExperienced. Learn about Adrenocortical Carcinoma.
- AgranulocytosisDr. Aghalar isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Aghalar isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Aghalar isExperienced. Learn about Alveolar Soft Part Sarcoma.